These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 11706924)

  • 21. Optimisation of itraconazole therapy using target drug concentrations.
    Poirier JM; Cheymol G
    Clin Pharmacokinet; 1998 Dec; 35(6):461-73. PubMed ID: 9884817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of antibiotics in dental practice.
    Montgomery EH; Kroeger DC
    Dent Clin North Am; 1984 Jul; 28(3):433-53. PubMed ID: 6589179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
    Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspofungin acetate: an antifungal agent.
    Hoang A
    Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic/pharmacodynamic profile of voriconazole.
    Theuretzbacher U; Ihle F; Derendorf H
    Clin Pharmacokinet; 2006; 45(7):649-63. PubMed ID: 16802848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcal skin infections in children: rational drug therapy recommendations.
    Ladhani S; Garbash M
    Paediatr Drugs; 2005; 7(2):77-102. PubMed ID: 15871629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Wiseman LR; Wagstaff AJ; Brogden RN; Bryson HM
    Drugs; 1995 Jul; 50(1):73-101. PubMed ID: 7588092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Thalhammer F; Hörl WH
    Clin Pharmacokinet; 2000 Oct; 39(4):271-9. PubMed ID: 11069213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antifungal agents for the systemic mycoses.
    Ringel SM
    Mycopathologia; 1990 Feb; 109(2):75-87. PubMed ID: 2157984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Penetration of antibiotics into the cerebrospinal fluid. Theoretical and practical aspects (author's transl)].
    Modai J
    Nouv Presse Med; 1980 Dec; 9(47):3615-20. PubMed ID: 6937071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children.
    Capitano B; Quintiliani R; Nightingale CH; Nicolau DP
    Paediatr Drugs; 2001; 3(10):703-18. PubMed ID: 11706922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.